CH391L/S12/Artemisinic Acid Engineering

From OpenWetWare
Revision as of 15:32, 2 April 2012 by Peter Otoupal (talk | contribs)
Jump to navigationJump to search

  • NOTE* Page is still under construction. As long as this note appears, assume information presented on this page is incomplete and unreliable.


Types of Selectable Markers





Types of Screening

Blue/White Screening

Green Fluorescent Protein Screening

Artificial Selection

Previous iGEM Examples

There has been no incidence of previous iGEM teams investigating Artemisinin or any of its precursors. Many iGEM teams have referenced Ro et al., but only as an example of pathway engineering, or in order to discuss ethics and synthetic biology's potential to positively benefit society. No parts in the parts registry deals with Artemisinin either. Only one [set of parts] mentions a protein, Granulysin, which can potentially be used to fight Malaria.


  1. Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, Chang MC, Withers ST, Shiba Y, Sarpong R, and Keasling JD. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature. 2006 Apr 13;440(7086):940-3. DOI:10.1038/nature04640 | PubMed ID:16612385 | HubMed [Ro2006]
  2. Chang MC, Eachus RA, Trieu W, Ro DK, and Keasling JD. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat Chem Biol. 2007 May;3(5):274-7. DOI:10.1038/nchembio875 | PubMed ID:17438551 | HubMed [Chang2007]

All Medline abstracts: PubMed | HubMed